| Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing … M Li, F Gao, JR Mascola, L Stamatatos, VR Polonis, M Koutsoukos, ... Journal of virology 79 (16), 10108-10125, 2005 | 1271 | 2005 |
| Rational HIV immunogen design to target specific germline B cell receptors J Jardine, JP Julien, S Menis, T Ota, O Kalyuzhniy, A McGuire, D Sok, ... Science 340 (6133), 711-716, 2013 | 812 | 2013 |
| Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection DN Sather, J Armann, LK Ching, A Mavrantoni, G Sellhorn, Z Caldwell, ... Journal of virology 83 (2), 757-769, 2009 | 655 | 2009 |
| Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine? L Stamatatos, L Morris, DR Burton, JR Mascola Nature medicine 15 (8), 866-870, 2009 | 571 | 2009 |
| mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection L Stamatatos, J Czartoski, YH Wan, LJ Homad, V Rubin, H Glantz, ... Science 372 (6549), 1413-1418, 2021 | 548 | 2021 |
| Interactions of cationic lipid vesicles with negatively charged phospholipid vesicles and biological membranes L Stamatatos, R Leventis, MJ Zuckermann, JR Silvius Biochemistry 27 (11), 3917-3925, 1988 | 425 | 1988 |
| Characteristics of the earliest cross-neutralizing antibody response to HIV-1 I Mikell, DN Sather, SA Kalams, M Altfeld, G Alter, L Stamatatos PLoS pathogens 7 (1), e1001251, 2011 | 408 | 2011 |
| Analysis of a SARS-CoV-2-infected individual reveals development of potent neutralizing antibodies with limited somatic mutation E Seydoux, LJ Homad, AJ MacCamy, KR Parks, NK Hurlburt, ... Immunity 53 (1), 98-105. e5, 2020 | 395 | 2020 |
| Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies AT McGuire, S Hoot, AM Dreyer, A Lippy, A Stuart, KW Cohen, J Jardine, ... Journal of Experimental Medicine 210 (4), 655-663, 2013 | 352 | 2013 |
| Structural repertoire of HIV-1-neutralizing antibodies targeting the CD4 supersite in 14 donors T Zhou, RM Lynch, L Chen, P Acharya, X Wu, NA Doria-Rose, MG Joyce, ... Cell 161 (6), 1280-1292, 2015 | 321 | 2015 |
| Immunization for HIV-1 broadly neutralizing antibodies in human Ig knockin mice P Dosenovic, L von Boehmer, A Escolano, J Jardine, NT Freund, AD Gitlin, ... Cell 161 (7), 1505-1515, 2015 | 302 | 2015 |
| The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following … SW Barnett, S Lu, I Srivastava, S Cherpelis, A Gettie, J Blanchard, S Wang, ... Journal of virology 75 (12), 5526-5540, 2001 | 291 | 2001 |
| Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study KM Hastie, H Li, D Bedinger, SL Schendel, SM Dennison, K Li, ... Science 374 (6566), 472-478, 2021 | 260 | 2021 |
| Computational design of epitope-scaffolds allows induction of antibodies specific for a poorly immunogenic HIV vaccine epitope BE Correia, YEA Ban, MA Holmes, H Xu, K Ellingson, Z Kraft, C Carrico, ... Structure 18 (9), 1116-1126, 2010 | 259 | 2010 |
| Recombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bNAbs S Hoot, AT McGuire, KW Cohen, RK Strong, L Hangartner, F Klein, ... PLoS pathogens 9 (1), e1003106, 2013 | 229 | 2013 |
| Induction of HIV neutralizing antibody lineages in mice with diverse precursor repertoires M Tian, C Cheng, X Chen, H Duan, HL Cheng, M Dao, Z Sheng, M Kimble, ... Cell 166 (6), 1471-1484. e18, 2016 | 224 | 2016 |
| N-linked glycosylation of the V3 loop and the immunologically silent face of gp120 protects human immunodeficiency virus type 1 SF162 from neutralization by anti-gp120 and anti … RA McCaffrey, C Saunders, M Hensel, L Stamatatos Journal of virology 78 (7), 3279-3295, 2004 | 218 | 2004 |
| Macrophage tropism of human immunodeficiency virus type 1 and utilization of the CC-CKR5 coreceptor C Cheng-Mayer, R Liu, NR Landau, L Stamatatos Journal of virology 71 (2), 1657-1661, 1997 | 210 | 1997 |
| V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from … A Ly, L Stamatatos Journal of virology 74 (15), 6769-6776, 2000 | 207 | 2000 |
| Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice AT McGuire, MD Gray, P Dosenovic, AD Gitlin, NT Freund, J Petersen, ... Nature communications 7 (1), 10618, 2016 | 190 | 2016 |
